Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Enzyme-Linked Immunosorbent Assay

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clinical Utility of Whole RNA Sequencing for Fusion Detection in Acute Leukemia.

Cells·2026

Same author

RMAD1, a Novel Cell-Penetrating Peptide Derived from ADARB2: Preclinical Insights into Antigen Uptake and T Cell Activation.

International journal of biological sciences·2026

Same author

Cell-Free Protein Synthesis in Porous Parylene Scaffolds.

Small methods·2026

Same author

A framework for building a synthetic cell from the SynCell Asia Initiative.

Nature biotechnology·2026

Same author

Comparative evaluation of two NGS-based assays for somatic hypermutation analysis of IGHV genes in chronic lymphocytic leukemia.

Blood research·2026

Same author

Nucleic acid detection via protein readout through Cas-controlled gating of cell-free protein synthesis.

Biosensors & bioelectronics·2026

Same journal

A Coumarin-Based Probe for Sequential ON-OFF-ON Detection of Cu<sup>2+</sup> and Biothiols: Naked-Eye Detection, Smartphone RGB Readout and In Vivo Imaging.

Biosensors·2026

Same journal

Electropolymerized Molecularly Imprinted Polymers Supported on Carbon-Based Materials for (Bio)sensing: Direct and Indirect Detection Strategies.

Biosensors·2026

Same journal

Progress in (Photo)electrochemical Biosensors for the Detection of Amyloid-Beta Oligomer.

Biosensors·2026

Same journal

Design and Simulation of Lamotrigine Intermittent Release from a Subcutaneous Implant with an Enzymatic Biosensor Based on Clinical Data.

Biosensors·2026

Same journal

Prediction of Chronic Kidney Disease Based on Simulated Serum Analysis by Vibrational Spectroscopy.

Biosensors·2026

Same journal

AI/ML-Assisted SERS Biosensing for Biomolecular Detection: From Direct Spectral Response to Integrated Diagnostic Systems.

Biosensors·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Sep 13, 2025

Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials

Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials

Published on: March 9, 2017

Enhancing ELISA Sensitivity: From Surface Engineering to Synthetic Biology.

Hye-Bin Jeon¹, Dong-Yeon Song¹, Yu Jin Park¹

¹Department of Chemical Engineering and Applied Chemistry, Chungnam National University, Daejeon 34134, Republic of Korea.

|July 25, 2025

Summary

This summary is machine-generated.

Enhancing enzyme-linked immunosorbent assays (ELISA) with synthetic biology boosts sensitivity for improved in vitro diagnostics. These advanced methods offer greater accuracy and accessibility for disease detection.

Keywords:

biomarker cell-free synthetic biology enzyme-linked immunosorbent assay (ELISA)in vitro diagnostic sensitivity

More Related Videos

Surface Enhanced Raman Spectroscopy Detection of Biomolecules Using EBL Fabricated Nanostructured Substrates

Surface Enhanced Raman Spectroscopy Detection of Biomolecules Using EBL Fabricated Nanostructured Substrates

Published on: March 20, 2015

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum

Published on: December 13, 2017

Related Experiment Videos

Last Updated: Sep 13, 2025

Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials

Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials

Published on: March 9, 2017

Surface Enhanced Raman Spectroscopy Detection of Biomolecules Using EBL Fabricated Nanostructured Substrates

Surface Enhanced Raman Spectroscopy Detection of Biomolecules Using EBL Fabricated Nanostructured Substrates

Published on: March 20, 2015

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum

Published on: December 13, 2017

Area of Science:

Biotechnology
Molecular Diagnostics
Assay Development

Background:

Accurate protein biomarker detection is crucial for in vitro diagnostics (IVD).
Conventional enzyme-linked immunosorbent assays (ELISA) often lack the sensitivity of nucleic acid tests.
A sensitivity gap hinders diagnostic accuracy for diseases where protein levels are key indicators.

Purpose of the Study:

To review strategies for enhancing ELISA sensitivity.
To explore the integration of synthetic biology into ELISA workflows.
To highlight advancements for next-generation programmable immunoassays.

Main Methods:

Surface modifications for improved assay performance.
Optimized mixing and washing protocols.
Novel signal generation and amplification techniques, including cell-free synthetic biology.

Main Results:

Emerging technologies like expression immunoassays, CRISPR-linked immunoassays (CLISA), and T7 RNA polymerase-linked immunosensing assays (TLISA) show promise.
Programmable nucleic acid and protein synthesis systems enhance ELISA sensitivity.
Integration of synthetic biology amplifies signals and improves overall assay performance.

Conclusions:

Synthetic biology significantly augments ELISA sensitivity.
ELISA, enhanced by synthetic biology, can achieve superior sensitivity, affordability, and accessibility.
This evolution positions ELISA as a modular, adaptable platform for highly sensitive, programmable immunoassays.